Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 1, 2007, Pages 196-203

 

^a Kilic), Diclehan   (Turkey)

Author keywords

Gelatinase; Matrix metalloproteinase; Preoperative treatment; Radiotherapy; Rectal cancer

Indexed keywords

CHEMOTHERAPY; PATHOLOGY; PATIENT TREATMENT; RADIOTHERAPY; SURGERY; TUMORS;

GELATINASE; MATRIX METALLOPROTEINASE; PREOPERATIVE TREATMENT; RECTAL CANCER;

PROTEINS;

FLUOROURACIL; FOLINATE CALCIUM; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE CYCLE TREATMENT; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33845627726     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.010     Document Type: Article

References (35)

1. Valentini V., Coco C., Picciochi A., et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53 (2002) 664-674
2. Garcia-Aguilar J., Hernandez de Anda E., Sirivongs P., et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46 (2003) 298-304
3. Rödel C., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
4. Vecchio F.M., Valentini V., Minsky B.D., et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 752-760
5. Unsal D., Tunc E., Mentes B.B., et al. The importance of pathologic complete response in rectal cancer patients treated by preoperative chemoradiotherapy. Int J Hematol Oncol 3 (2005) 120-131
6. Kumar A., Collins H., Van Tam J., et al. Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer. Eur J Cancer 38 (2002) 505-510
7. Zucker S., and Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 24 (2004) 101-117
8. Waas E.T., Lomme R.M., DeGroot J., et al. Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. Br J Cancer 86 (2002) 1876-1883
9. Zeng Z.S., Huang Y., Cohen A.M., et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 14 (1996) 3133-3140
10. Kim T.S., and Kim Y.B. Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma. J Korean Med Sci 14 (1999) 263-270
11. Roeb E., Dietrich C.G., Winograd R., et al. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 92 (2001) 2680-2691
12. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorect Dis 12 (1997) 19-23
13. Krajewska M., Wang H.G., Krajewski S., et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3) a cell death process. Cancer Res 57 (1997) 1605-1613
14. Masaki T., Sugiyama M., Matsuoka H., et al. Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas. Anticancer Res 23 (2003) 4169-4173
15. Leeman M.F., McKay J.A., and Murray G.I. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 55 (2002) 237-241
16. American Joint Committee on Cancer. AJCC cancer staging handbook. 6th ed (2002), Lippincott Raven, Philadelphia
17. Waas E.T., Wobbes T., Lomme R.M.L.M., et al. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90 (2003) 1556-1564
18. Zeng Z.S., and Guillem J.G. Colocalisation of matrix metalloproteinase-9 mRNA and protein in human colorectal cancer stromal cells. Br J Cancer 74 (1996) 1161-1167
19. Mook O.R.F., Frederiks W.M., and Van Noorden C.J.F. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705 (2004) 69-89
20. Ring P., Johansson H., Hoyhtya M., et al. Expression of tissue inhibitor of metalloproteinases TIMPP-2 in human colorectal cancer: A predictor of tumor stage. Br J Cancer 76 (1997) 805-811
21. Goh V., Halligans S., and Bartram C.I. Local radiological staging of rectal cancer. Clin Radiol 59 (2004) 215-226
22. Maldjian C., Smith R., Kilger A., et al. Endorectal surface coil MR imaging as a staging technique for rectal carcinoma: A comparison study to rectal endosonography. Abdom Imaging 25 (2000) 75-80
23. Kuo U., Chern M.C., Tsuo M.H., et al. Interpretation of magnetic resonance imaging of locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 48 (2005) 23-28
24. Chen C.C., Lee R.C., Lin J.K., et al. How accurate magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 48 (2005) 722-728
25. Yeoh A.S., Bowen J.M., Gibson R.J., et al. Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol Phys 63 (2005) 1295-1303
26. Kawano N., Osawa H., Ito N., et al. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin (ogen) in lung neoplasms: An immunohistochemical study. Hum Pathol 28 (1997) 613-622
27. Sinicrope F.A., Ruan S.B., Cleary K.R., et al. bcl-2 and p-53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55 (1995) 237-241
28. Wagenar-Miller R.A., Gorden L., and Matrisian L.M. Matrix metalloproteinases in colorectal cancer: Is it worth talking about?. Cancer Metastasis Rev 23 (2004) 119-135
29. Baker E.A., and Leaper D.J. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: Relationship to tumour pathology. Eur J Cancer 39 (2003) 981-988
30. Ornstein D.L., and Cohn K.H. Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium. Dig Dis Sci 47 (2002) 1821-1830
31. Jiang Y., Goldberg I.D., and Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21 (2002) 2245-2252
32. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
33. Kilic D., and Sayan H. The effect of granulocyte macrophage-colony stimulating factor on the prostaglandin E(2)-like activity of the small intestine of rat during total body irradiation. Prostaglandins Leuktr Essent Fatty Acids 62 (2000) 349-353
34. Kumar A., Collins H.M., Scholefield J.H., et al. Increased type IV collagenase (MMP-2 and MMP-9) activity following pre-operative radiotherapy in rectal cancer. Br J Cancer 84 (2000) 960-965
35. Hovdenak N., Wang J., Sung C.C., et al. Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 919-927